Table 3 Univariate cox proportional hazard modeling (K–M significant)
Glycan fragments | p value (log p) | HR (95% CI) |
|---|---|---|
Cancer cell region | ||
HexS | 0.023* | 0.47 (0.24–0.91) |
dHexHexS | 0.028* | 0.24 (0.058–0.96) |
HexHexNAcAc | 0.038* | 0.47 (0.22–0.97) |
HexHexNAcS | 0.01* | 0.39 (0.19–0.82) |
dHexPenHexAc | 0.027* | 0.60 (0.38–0.95) |
KdoHexAHexA | 0.011* | 0.29 (0.11–0.80) |
HexHexHexNAcS | 0.023* | 0.39 (0.17–0.91) |
HexHexNAcHexNAcS | 0.027* | 0.30 (0.092–0.93) |
HexNAcHexPNeuAc | 0.012* | 0.25 (0.079–0.80) |
dHexHexHexSHexNAc | 0.011* | 0.25 (0.079–0.80) |
HexA | 0.012* | 2.32 (1.19–4.53) |
Chondroitin or hyaluronan | 0.007** | 2.25 (1.23–4.10) |
HexAHexNAc | 0.007** | 2.25 (1.23–4.10) |
Chondroitin sulfate | 0.026* | 1.74 (1.06–2.85) |
dHexHexHexAMe | 0.025* | 2.19 (1.08–4.44) |
HexAHexNAcHexNAc | 0.038* | 2.25 (1.03–4.92) |
Stroma region | ||
HexS | 0.0028** | 0.50 (0.32–0.80) |
N-Acetylhexosamine sulfate | 0.040* | 2.00 (1.02–3.91) |
HexAHexNAc | 0.027* | 1.97 (1.07–3.61) |
N-Acetylhexosamine disulfate | 0.020* | 2.49 (1.12–5.52) |
HexANAcS | 0.012* | 2.19 (1.17–4.09) |